You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RoACTEMRA

Showing 1 - 25 of 206
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Men Trial in Hefei (BAT1806 prefilled subcutaneous injection/RoActemra® (from EU))

Not yet recruiting
  • Healthy Men
  • BAT1806 prefilled subcutaneous injection/RoActemra® (from EU)
  • Hefei, Anhui, China
    The Second Affiliated Hospital of Anhui Medical University
Jul 27, 2023

Rheumatoid Arthritis Trial (CT-P47, EU-approved RoActemra)

Not yet recruiting
  • Rheumatoid Arthritis
  • CT-P47
  • EU-approved RoActemra
  • (no location specified)
Aug 16, 2022

Healthy Subjects Trial in Seoul (CT-P47, EU-approved RoActemra,)

Recruiting
  • Healthy Subjects
  • CT-P47
  • EU-approved RoActemra,
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Dec 27, 2021

Chronic Subdural Hematoma Trial in Oslo (Tranexamic acid and Tocilizumab)

Terminated
  • Chronic Subdural Hematoma
  • Tranexamic acid and Tocilizumab
  • Oslo, Norway
    Milo Stanisic
Oct 5, 2021

Inflammatory Disease, Autoimmune Diseases Trial in Paris (Kineret, Humira, Stelara)

Recruiting
  • Inflammatory Disease
  • Autoimmune Diseases
  • Paris, France
    Hôpital Cochin
Oct 10, 2022

Systemic Lupus Erythematosus Trial (RO7507062, Tocilizumab)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • (no location specified)
Apr 19, 2023

Rheumatoid Arthritis Trial in Beijing (BAT1806, Actemra(EU-licensed))

Completed
  • Rheumatoid Arthritis
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Nov 16, 2021

Renal Cell Carcinoma, NSCLC, Pancreatic Adenocarcinoma, Colorectal Cancer Trial (RO7515629, tocilizumab)

Not yet recruiting
  • Renal Cell Carcinoma, Non-small Cell Lung Cancer, Pancreatic Adenocarcinoma, Colorectal Cancer
  • (no location specified)
Mar 3, 2023

Esophageal Adenocarcinoma, Oesophageal Adenocarcinoma, Resectable Carcinoma Trial in Amsterdam (Tocilizumab 20 Mg/mL Intravenous

Active, not recruiting
  • Esophageal Adenocarcinoma
  • +2 more
  • Tocilizumab 20 Mg/mL Intravenous Solution
  • +3 more
  • Amsterdam, Netherlands
    Academic Medical Center, Medical Oncology
Dec 15, 2022

Arthritis, Rheumatoid, Interaction Trial in Esbjerg, Odense, Sønderborg (Tocilizumab, Sarilumab)

Terminated
  • Arthritis, Rheumatoid
  • Interaction
  • Esbjerg, Region Of Southern Denmark, Denmark
  • +2 more
Jan 20, 2023

Granulomatosis With Polyangiitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Paris (Rituximab,

Not yet recruiting
  • Granulomatosis With Polyangiitis
  • Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
  • Paris, France
    Hôpital de la Croix Saint Simon
Oct 10, 2022

Multiple Myeloma Trial in Athens (Cevostamab, XmAb24306, Tocilizumab)

Recruiting
  • Multiple Myeloma
  • Athens, Greece
  • +1 more
Jan 2, 2023

Coronary Artery Disease, Aortic Valve Disease Trial in Copenhagen (Tocilizumab, Isotonic sodium chloride (0.9%), Dexamethasone

Recruiting
  • Coronary Artery Disease
  • Aortic Valve Disease
  • Copenhagen, Denmark
    The Heart Centre, Rigshospitalet
Nov 29, 2022

Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Chiba, Tokyo (RO7616789, Tocilizumab)

Recruiting
  • Small Cell Lung Cancer
  • Neuroendocrine Carcinoma
  • Chiba, Japan
  • +1 more
Jan 16, 2023

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta (Tocilizumab, Venetoclax)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jan 24, 2023

Rheumatoid Arthritis Trial in France (subcutaneous tocilizumab)

Recruiting
  • Rheumatoid Arthritis
  • subcutaneous tocilizumab
  • Lyon, France
  • +3 more
Jun 13, 2022

Rheumatoid Arthritis, Giant Cell Arteritis Trial in Australia, India, New Zealand (Tocilizumab Prefilled Syringe)

Active, not recruiting
  • Rheumatoid Arthritis
  • Giant Cell Arteritis
  • Tocilizumab Prefilled Syringe
  • Brisbane, Australia
  • +3 more
May 4, 2022

Acute Myocardial Infarction, Cardiogenic Shock Trial in Copenhagen (Tocilizumab, Dobutamine, NaCl 0.9%)

Recruiting
  • Acute Myocardial Infarction
  • Cardiogenic Shock
  • Copenhagen, Denmark
    Rigshospitalet, Copenhagen University Hospital
Apr 21, 2022

Antibody-mediated Rejection Trial in Gothenburg, Stockholm, Uppsala (Tocilizumab)

Recruiting
  • Antibody-mediated Rejection
  • Gothenburg, Vastra Gotaland Regioin, Sweden
  • +2 more
Feb 16, 2022

COVID-19, Pneumonia, Viral Trial in Spain (Tocilizumab, Pembrolizumab (MK-3475))

Terminated
  • COVID-19
  • Pneumonia, Viral
  • Barcelona, Spain
  • +6 more
Jun 14, 2022

Giant Cell Arteritis Trial in Basel, Bern (Tocilizumab)

Completed
Has Results
  • Giant Cell Arteritis
  • Basel, Switzerland
  • +1 more
Nov 4, 2021

Multiple Myeloma Trial in Worldwide (Cevostamab, Tocilizumab, Pomalidomide)

Recruiting
  • Multiple Myeloma
  • Duarte, California
  • +7 more
Aug 17, 2022

Rheumatoid Arthritis Trial in Paris (Tocilizumab, Abatacept, Decrease Tocilizumab, Abatacept)

Completed
  • Rheumatoid Arthritis
  • Tocilizumab, Abatacept
  • Decrease Tocilizumab, Abatacept
  • Paris, France
    CHU Pitié Salpêtrière
Jan 24, 2021

Juvenile Idiopathic Arthritis Trial in Paris (etanercept, adalimumab, Abatacept)

Completed
  • Juvenile Idiopathic Arthritis
  • Paris, France
    Necker Children's Hospital
Mar 31, 2021

Giant Cell Arteritis, Neurovascular Disorder Trial in Paris (Tocilizumab, Placebo)

Not yet recruiting
  • Giant Cell Arteritis
  • Neurovascular Disorder
  • Paris, France
    Saint Antoine Hospital, Neurology Unit, Assistance Publique-Hôpi
May 14, 2021